Back

Company Profile

Trapeze Associates Pty Ltd is an import & distribution company specialising in sourcing and supplying raw materials to the pharmaceutical, veterinary, nutraceutical and personal care industries in Australia and New Zealand.

Giz and Michael Travers established the company in May 1999 to purchase, through an MBO, the active pharmaceutical ingredients business of Aventis Pharma Pty Ltd.

The business has had a long and successful history having been founded almost 50 years ago by Roussel Uclaf and since that time through a succession of global mergers and acquisitions has traded under a number of names including Roussel Uclaf Australia, Hoechst Marion Roussel, Aventis and now Trapeze Associates. 

Trapeze has exclusive representation with over 30 major manufacturers of API's and excipients and close sourcing relationships with a further 50 manufacturers around the world.

Trapeze Associates are a small close-knit team dedicated to supplying quality products with exceptional customer service. The two directors of the company have over 35 years combined experience in the fine chemical and pharmaceutical industries.

Working in partnership with both customers and suppliers Trapeze ensures that not only the quality of the product matches the customers expectations but that the supply chain process operates smoothly to ensure that service expectations are equally met.

The business is headquartered at Norwest Business Park in Bella Vista, NSW; an interstate office is located in Clayton, VIC and operates in NZ through its sister company Trapeze Associates Limited based in Albany, Auckland. Trapeze provides an ex-stock service through a network of Australian and New Zealand warehouses and is licensed to store and distribute a range of Schedule Poisons as specified by State and Federal Legislation.

Product registration and associated compliance issues form part of the overall Trapeze service offered to existing and new suppliers ensuring that the timeline for importing new products into the Australian and New Zealand markets is optimised.